alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
1

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

BRIAN P. BERSON, ESQ.

1000 Brannan St., Suite 488

San Francisco, CA 94103

California State Bar No. 130249

brian@bersonlaw.net

Telephone No.:(415)788-2707

Facsimile No.:(415)522-5206

Counsel for Defendant DONNA MARR

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA 

) No.CR-17-080-YGR

UNITED STATES OF AMERICA, ) 

 Plaintiff, ) STIPULATION AND 

) [PROPOSED] ORDER CONTINUING

vs. ) SENTENCING

)

DONNA MARR

Defendant. ) 

)

STIPULATION

 Sentencing is currently set on July 21, 2017 at 10:00 a.m. 

The parties jointly request that sentencing be continued to August 

17, 2017, in order to accommodate logistical issues caused by outof-town plans of counsel and the USPO assigned to do the 

presentence report (PSR). 

 Respectfully Submitted,

Date: May 30, 2017 _/S/-Brian Berson_____

 BRIAN P. BERSON

 Attorney for Donna Marr

*AS MODIFIED BY THE COURT*
2

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

 

Date: May 30, 2017 _/S/-Joseph M. Alioto, Jr. 

 JOSEPH ALIOTO, JR. 

 Assistant United States Attorney

 

 

[PROPOSED] ORDER 

 

 For the reasons stated above, the sentencing will be 

continued from July 21, 2017 to :HGQHVGD\August 1, 2017 atSP. 

 So ordered. 

 

 

Dated:_____________ ___________________________ 

 THE HONORABLE YVONNE GONZALEZ ROGERS 

 United States District Judge 

May 31, 2017
Ginger Ann QUEEN a/k/a Ginger Queen, Appellant, v. U.S. BANK NATIONAL ASSOCIATION, as trustee, successor in interest to Bank of America, National Association, as trustee, successor by merger to Lasalle Bank National Association, as trustee for Merrill Lynch Mortgage Investors Trust, Mortgage Loan Asset-Backed Certificates, Series 2006-WMC2, Appellee.

Case No. 2D18-2359

District Court of Appeal of Florida, Second District.

Opinion filed July 12, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Matter of Davis

2023 NY Slip Op 34557(U)

December 28, 2023

Surrogate's Court, New York County

Docket Number: File No. 2020-1709/A/B/C

Judge: Hilary Gingold

Cases posted with a "30000" identifier, i.e., 2013 NY Slip

Op 30001(U), are republished from various New York

State and local government sources, including the New

York State Unified Court System's eCourts Service.

This opinion is uncorrected and not selected for official

publication.
[* 1]
[* 2]
[* 3]
[* 4]
G.G. v. T.R.M.

2170335

Court of Civil Appeals of Alabama.

January 30, 2018

Dismissed.
EXHIBIT 99.2

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Eclipse  Entertainment  Group, Inc. (the
"Company") on Form 10-KSB/A for the year ending December 31, 2002, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I, Art
Birzneck, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.

/s/ ART BIRZNECK
-------------------------------------------
Art Birzneck, Chief Financial Officer
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                          31,471
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                17,800
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    229,826
<INVESTMENTS-CARRYING>                         122,791
<INVESTMENTS-MARKET>                           355,182
<LOANS>                                        545,419
<ALLOWANCE>                                      7,285
<TOTAL-ASSETS>                                 979,196
<DEPOSITS>                                     798,099
<SHORT-TERM>                                    59,277
<LIABILITIES-OTHER>                              6,960
<LONG-TERM>                                     54,360
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        31,686
<OTHER-SE>                                      28,814
<TOTAL-LIABILITIES-AND-EQUITY>                 979,196
<INTEREST-LOAN>                                 35,430
<INTEREST-INVEST>                               16,277
<INTEREST-OTHER>                                   446
<INTEREST-TOTAL>                                52,153
<INTEREST-DEPOSIT>                              22,219
<INTEREST-EXPENSE>                              27,150
<INTEREST-INCOME-NET>                           25,003
<LOAN-LOSSES>                                    1,970
<SECURITIES-GAINS>                                 740
<EXPENSE-OTHER>                                 15,698
<INCOME-PRETAX>                                 10,710
<INCOME-PRE-EXTRAORDINARY>                       7,524
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     7,524
<EPS-PRIMARY>                                     1.12
<EPS-DILUTED>                                     1.12
<YIELD-ACTUAL>                                       0
<LOANS-NON>                                      7,560
<LOANS-PAST>                                     1,551
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 5,742
<CHARGE-OFFS>                                      502
<RECOVERIES>                                        75
<ALLOWANCE-CLOSE>                                7,285
<ALLOWANCE-DOMESTIC>                             7,285
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
Ernest S. MARSHALL and Patricia K. Marshall, Former Permanent Guardians; and Jill P. Zink, Appellants, v. Bryan T. ZINK, Appellee.

Case No. 2D18-1603

District Court of Appeal of Florida, Second District.

Opinion filed March 6, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
condensed consolidated financial statements included in the Form 10-Q of Dionex
Corporation for the quarter ended December 31, 1998 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-END>                               DEC-31-1998
<CASH>                                            6893
<SECURITIES>                                         0
<RECEIVABLES>                                    35787
<ALLOWANCES>                                       632
<INVENTORY>                                      11808
<CURRENT-ASSETS>                                 65273
<PP&E>                                           57778
<DEPRECIATION>                                   17423
<TOTAL-ASSETS>                                  131530
<CURRENT-LIABILITIES>                            39184
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         44650
<OTHER-SE>                                       39756
<TOTAL-LIABILITY-AND-EQUITY>                    131530
<SALES>                                          79350
<TOTAL-REVENUES>                                 79350
<CGS>                                            27323
<TOTAL-COSTS>                                    27323
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 143
<INCOME-PRETAX>                                  15161
<INCOME-TAX>                                      5079
<INCOME-CONTINUING>                              10082
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     10082
<EPS-PRIMARY>                                      .45
<EPS-DILUTED>                                      .43
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CENTOCOR,
INC. CONSOLIDATED BALANCE SHEETS, CENTOCOR, INC. CONSOLIDATED STATEMENTS OF
OPERATIONS AND IS QUALIFIED IN ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> US DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<EXCHANGE-RATE>                                      1
<CASH>                                          56,364
<SECURITIES>                                   105,782
<RECEIVABLES>                                   49,729
<ALLOWANCES>                                         0
<INVENTORY>                                     21,324
<CURRENT-ASSETS>                               236,973
<PP&E>                                         137,445
<DEPRECIATION>                                  77,048
<TOTAL-ASSETS>                                 366,105
<CURRENT-LIABILITIES>                           63,355
<BONDS>                                         54,765
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           697
<OTHER-SE>                                     241,286
<TOTAL-LIABILITY-AND-EQUITY>                   366,105
<SALES>                                         95,943
<TOTAL-REVENUES>                                98,679
<CGS>                                           39,989
<TOTAL-COSTS>                                   39,989
<OTHER-EXPENSES>                                57,249
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,962
<INCOME-PRETAX>                                  4,081
<INCOME-TAX>                                        90
<INCOME-CONTINUING>                              3,991
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,991
<EPS-PRIMARY>                                    $0.06
<EPS-DILUTED>                                    $0.06
        

</TABLE>
Exhibit
32.1





Written
Statement of Chief Executive Officer


Pursuant to 18 U.S.C.
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002








The
undersigned, the Chief Executive Officer of The Wilber Corporation (the
"Company"), hereby certifies that to his knowledge on the date
hereof:





(a)
            the
      Form 10-Q of the Company for the Quarterly Period Ended March 31, 2008,
      filed on the date hereof with the Securities and Exchange Commission (the
      "Report"), fully complies with the requirements of Section 13(a) or 15(d)
      of the Securities Exchange Act of 1934;
and





(b)
            information
      contained in the Report fairly presents, in all material respects, the
      financial condition and results of operations of the
    Company.








/s/ Douglas C.
      GulottyDouglas
      C. GulottyPresident
      and Chief Executive OfficerDate:  May 7,
      2008





A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to The Wilber Corporation and will be retained
by The Wilber Corporation and furnished to the Securities and Exchange
Commission or its staff upon request.




35
#1 ANYTIME BAIL 24/7 INC. and Financial Casualty & Surety, Inc., Appellants, v. STATE of Florida and Clerk of the Circuit Court for Citrus County, Florida, Appellees.

Case No. 5D18-2681

District Court of Appeal of Florida, Fifth District.

Opinion filed July 9, 2019

James Patrick Tarquin, Ocala, for Appellants.

Ashley Moody, Attorney General, Tallahassee, and Shelley Cridlin, Senior Assistant Attorney General, Tampa, for Appellee, State of Florida.

Adam A. Czaya, of Keith Taylor Law Group, P.A., Lecanto, for Appellee, Clerk of the Circuit Court for Citrus County, Florida.

PER CURIAM.

AFFIRMED. *See**Cty. of Volusia v. Audet*, 682 So. 2d 687 (Fla. 5th DCA 1996).

COHEN, EDWARDS and GROSSHANS, JJ., concur.
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT

ELIZABETH DENBY MARSHALL, ) ) Appellant, ) ) v. ) Case No. 2D17-2917 ) MICHAEL J. MULLAUGH and BANK OF ) NEW YORK MELLON, as PERSONAL ) REPRESENTATIVES of THE ESTATE ) OF PEGGY A. DENBY, DECEASED, ) ) Appellees. ) ) Opinion filed February 14, 2018. Appeal pursuant to Fla. R. App. P. 9.130 from the Circuit Court for Lee County; Michael T. McHugh, Judge. Theodore L. Tripp, Jr., and Jamie B. Schwinghamer of Hahn Loeser & Parks LLP, Naples; Kenneth E. Kemp, II of Patrone & Kemp, P.A., Fort Myers, for Appellant. Jennifer R. Dixon of Lowndes, Drosdick, Doster, Kantor & Reed, P.A., Orlando, for Appellee.

PER CURIAM.

Affirmed.
NORTHCUTT, KELLY, and SALARIO, JJ., Concur.
Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Historical Status of OTC Rulemakings

Historical Status of OTC Rulemakings Home
          Drugs
          Development & Approval Process | Drugs
          How Drugs are Developed and Approved
          Over-the-Counter OTC | Nonprescription Drugs
          Historical Status of OTC Rulemakings
          Rulemaking History for OTC Diaper Rash Drug ProductsHistorical Status of OTC Rulemakings Rulemaking History for OTC Diaper Rash Drug Products
  
  	
    Share
    Post
    Linkedin

    Email
    PrintOTC Diaper Rash Drug Product information can be found on the following pages:External AnalgesicTopical AntifungalTopical AntimicrobialSkin Protectant

                                                                                  Content current as of:
      06/12/2018Historical Status of OTC Rulemakings
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop
Exhibit
32.1





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED


PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Smartmetric, Inc. (the “Company”) on
Form 10-Q for the period ended September 30, 2009, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Colin Hendrick,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section
1350 of the Sarbanes-Oxley Act of 2002, that:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.





The
foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. section 1350 and is not being filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or
after the date hereof, regardless of any general incorporation language in such
filing.





Dated: November
      23, 2009
            By:
            /s/ Colin
      HendrickColin
      HendrickPresident
      (Principal Executive Officer)
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                          25,295
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 3,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    207,490
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                        611,583
<ALLOWANCE>                                      8,455
<TOTAL-ASSETS>                                 877,311
<DEPOSITS>                                     734,149
<SHORT-TERM>                                    15,222
<LIABILITIES-OTHER>                              6,674
<LONG-TERM>                                     48,156
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         5,222
<OTHER-SE>                                      67,888
<TOTAL-LIABILITIES-AND-EQUITY>                 877,311
<INTEREST-LOAN>                                 12,546
<INTEREST-INVEST>                                2,871
<INTEREST-OTHER>                                   140
<INTEREST-TOTAL>                                15,557
<INTEREST-DEPOSIT>                               6,725
<INTEREST-EXPENSE>                               7,728
<INTEREST-INCOME-NET>                            7,829
<LOAN-LOSSES>                                      375
<SECURITIES-GAINS>                                  12
<EXPENSE-OTHER>                                  7,653
<INCOME-PRETAX>                                  3,197
<INCOME-PRE-EXTRAORDINARY>                       2,368
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,368
<EPS-PRIMARY>                                      .46
<EPS-DILUTED>                                      .45
<YIELD-ACTUAL>                                    4.16
<LOANS-NON>                                      4,811
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                   386
<LOANS-PROBLEM>                                  5,197
<ALLOWANCE-OPEN>                                 8,507
<CHARGE-OFFS>                                      650
<RECOVERIES>                                       224
<ALLOWANCE-CLOSE>                                8,456
<ALLOWANCE-DOMESTIC>                             8,456
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in Local Rule

47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 96-10268

Conference Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

JESUS HERNANDEZ,

Defendant-Appellant.

- - - - - - - - - -

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 4:95-CR-102-Y

- - - - - - - - - -

December 10, 1996

Before WIENER, BARKSDALE, and BENAVIDES, Circuit Judges. 

PER CURIAM:*

Jesus Hernandez appeals the 87-month sentence imposed by the

district court following the acceptance of his guilty plea for

possession with intent to distribute methamphetamine. Hernandez

argues that the district court clearly erred in not finding that

he was a minor participant in the drug conspiracy and reducing

his offense level accordingly under § 3B1.2 of the U.S.

Sentencing Guidelines. Because Hernandez was responsible for a
No. 96-10268

- 2 -

large quantity of methamphetamine, 1.8 kilograms, seized from his

residence, and because he was held responsible for only the

amount of drugs that he actually possessed, § 3B1.2 does not

require a reduction in his base offense level even though his

activity in the overall drug conspiracy may have been minor. 

United States v. Atanda, 60 F.3d 196, 199 (5th Cir. 1995); United

States v. Lampkins, 47 F.3d 175, 180-81 (7th Cir.), cert. denied,

115 S. Ct. 1440 (1995). 

AFFIRMED.